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Abstract

Results
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Generalized anxiety disorder (GAD) involves dysregulation of worry for more
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than 6 months. Symptoms include fatigue, insomnia and irritability. Medications • RCT of 72 participants were involved in a study to examine the efficacy of mindfulness meditation in the treatment of
such as SSRIs may cause constipation, lower libido and cause withdrawal
Generalized anxiety disorder when compared to ‘Stress management education’
symptoms when discontinued. Alternative therapies like mindfulness
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meditation teach patients breath awareness and to redirect unwanted negative utilization in individuals with anxiety. J Psychosomatic Research. 2017; 95: 7-11
thoughts to positive ones. This paper examines the efficacy of mindfulness
• RCT of 57 participants were involved in a study to examine the efficacy of mindfulness meditation in occupational
meditation treatment (I) for managing symptoms of anxiety (O) in adult patients
functioning in those diagnosed with Generalized anxiety disorder when compared to ‘Stress management education’
with mild-moderate GAD (P) in comparison to stress management education
3) Hoge EA, Bui E, Goetter E, et al. Change in Decentering Mediates Improvement in Anxiety in Mindfulness-Based
(C).
Stress Reduction for Generalized Anxiety Disorder. Cognit Ther Res. 2015;39(2):228-235
• RCT of 38 participants were involved in a study to examine the efficacy of mindfulness meditation in the treatment of
Generalized anxiety disorder when compared to ‘Stress management education’
4) Hoge EA, Bui E, Marques L, et al. Randomized controlled trial of mindfulness meditation for generalized anxiety
disorder: effects on anxiety and stress reactivity. J Clin Psychiatry. 2013;74(8):786-92.
Overview:
• RCT of 93 participants were involved in a study to examine the efficacy of mindfulness meditation in the treatment of
ØDysregulation of worry
Generalized anxiety disorder when compared to ‘Stress management education’ 4) Boettcher J et al. Internet-Based
ØLeads to recurrent activation of brain regions responsible for mental tasks
5)Mindfulness Treatment for Anxiety Disorders: A Randomized Controlled Trial. Behavioral Therapy. 2014; 45:241-253
• RCT of 91 participants were involved in a study to examine the efficacy of mindfulness meditation in the treatment of
ØTwin studies suggest that both genetic and environmental factors are involved
anxiety disorders when compared to an ‘online discussion control group’
Ø6% of the population living in the US have a lifetime prevalence of this disorder
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Øinclude fatigue, irritability, nervousness, insomnia, and muscle tension
• RCT of 182 participants were involved in a study to examine the efficacy of mindfulness meditation in the treatment
ØAssociated with depression, bipolar disorder and substance use disorder
of Generalized anxiety disorder when compared to ‘psychoeduction’
Treatment

Introduction

Study

Design Total
N

ØFirst line treatments include SSRIs and psychotherapy
ØStress management education (SME) educates patients on stress physiology, optimal
nutrition and cultivating resilience
Hoge, Bui, RCT
Palitz et al
ØMindfulness meditation has been studied as a possible alternative/adjunct.
(2018)
incorporates breathing exercises and conscious awareness of breath
ØUsing the body’s mechanics : Deep breathing exercises stimulate the vagus nerve

Methods
Literature search
ØPerformed in October 2018 using:
1) Google scholar.
2) PubMed
3)Ovid
ØSearch terms: mindfulness meditation AND generalized anxiety disorder AND
stress management education’
ØInclusion criteria:
oPublished 2013 or later
oWritten in English
oRandomized control trials with human test subjects, clinical trials and those
that were reviewed
ØExclusion criteria:
oStudies that involved clinical trials with animals
oStudies that did not include a clinical trial
oClinical trials involving adolescents younger than 18 years of age
oStudies that included an anxiety disorder that was not GAD
oStudies involving PTSD with anxiety
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(2017)

57
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Marques
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38

32 females
25 males

DSM IV
GAD

SME

Outcome
Measure
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of health
professional
visits

21 females
17 males

DSM IV
GAD

SME

1 session per
week x 8
Decentering,
weeks=
BAI, PSWQ
8 sessions

93
45 females
Hoge et al RCT
(2013)
44 males
Note: *p=.005
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GAD
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1 session per HAM-A, CGI-S,
week x 8
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weeks=
TSST
8 sessions

65 females
26 males

GAD
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ducatio week x 8
n
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144 females
38 males
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GAD
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complete
study
Boettcher RCT
et al
(2014)

91

Wong et al RCT
(2016)

182

6/6 studies report significant improvement in anxiety symptoms from the use
of mindfulness-based meditation in patients diagnosed with generalized
anxiety disorder (GAD). 5/6 studies show significant difference between
treatment and control groups (Wong’s study is the only one that didn’t)
Strengths
ØAll studies were based on RCTà unbiased distribution improving
credibility of studies
ØStatistically significant resultsà p value<0.05
ØAdequate treatment timeline à >8 weeks
ØNo study reported any adverse effect of mindfulness meditation treatment
Limitations
ØLimited monitoring of home-based meditation exercises
ØDrop outs in 4/6 studies and inadequate follow up
ØRecruitment methods
ØGender distribution
Future Research

1 session per Cortisol,
week x 8
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Discussion

Psychoe 1 session per BAI, PSWQ
ducatio week x 8
n
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8 sessions

Key:
RCT: Randomized Control Trial
GAD: General Anxiety Disorder
GAD 7: Generalized Anxiety
Disorder 7-item scale
SME: Stress management
education,
DSM IV: Diagnostic and
Statistical Manual of Mental
Disorders
ACTH: Adrenocorticotropic
hormone
IL-6: Interleukin-6
TNF-alpha: Tumor necrosis
factor-alpha
PSWQ: Penn State Worry
Questionnaire
FFMQ: Five Facet Mindfulness
Questionnaire
TSST: Trier social stress test
HAM-A: Hamilton Anxiety
Rating Scale
CGI-S: Clinical Global
Impression – Severity scale
CGI-I: Clinical Global Impression
– Improvement scale
BAI: Beck Anxiety Inventory

ØUtilize web-cam with live monitoring of home meditation exercises
ØMindfulness meditation as an adjunct therapy to pharmaceutical therapy
with SSRIs
ØSynergistic effects of psychotherapy and mindfulness meditation

Conclusion
The study results are promising, however more research with
improvements in experimental design are necessary to make a definitive
conclusion. Studies suggest that mindfulness meditation may be effective
in treating patients diagnosed with generalized anxiety disorder especially
those with complicated comorbidities, side effects or allergies.
However difficult to conclude that it can be used as an alternative to
pharmaceutical therapy as there is no study that makes a direct
comparison between the two. More research is necessary to determine
whether symptom relief from meditation can be sustained for long term
anxiety management (>6 months).
Future studies should aim to directly compare pharmaceutical therapy
with mindfulness meditation therapy. Another possibility is to compare
the synergistic effects of psychotherapy and mindfulness meditation with
pharmaceutical therapy with SSRI medication.
Overall, results of the meta-analysis are positive, but the evidence is
insufficient to justify any changes to clinical practice.

